摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Nα-(tert-butyloxycarbonyl)-Nα-methyl-Nim-tosyl-L-histidine | 103372-35-6

中文名称
——
中文别名
——
英文名称
Nα-(tert-butyloxycarbonyl)-Nα-methyl-Nim-tosyl-L-histidine
英文别名
Boc-N(Me)His(1-Tos)-OH;(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-3-[1-(4-methylphenyl)sulfonylimidazol-4-yl]propanoic acid
N<sup>α</sup>-(tert-butyloxycarbonyl)-N<sup>α</sup>-methyl-N<sup>im</sup>-tosyl-L-histidine化学式
CAS
103372-35-6
化学式
C19H25N3O6S
mdl
——
分子量
423.49
InChiKey
IIQNJQPKUVYPMV-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    615.2±65.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    29
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    127
  • 氢给体数:
    1
  • 氢受体数:
    7

SDS

SDS:b1a74bc2f885c1adba8433d589b68921
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Nα-(tert-butyloxycarbonyl)-Nα-methyl-Nim-tosyl-L-histidine 在 diethylphosphoryl cyanide 、 氰基磷酸二乙酯1-羟基苯并三唑三乙胺三氟乙酸 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 24.0h, 生成 地替吉仑
    参考文献:
    名称:
    设计和合成具有延长的体内作用时间的有效的特异性肾素抑制剂。
    摘要:
    对含有主链Cα-甲基和Nα-甲基修饰的肽进行结构活性分析导致发现了具有高代谢稳定性的有效肾素抑制剂。在体外,Boc-Pro-Phe-Nα-MeHis-Leupsi- [CHOHCH2] Val-Ile-Amp(XII)是人血浆肾素的有效抑制剂,IC50为0.26 nM。它是其他天冬氨酸蛋白酶(如猪胃蛋白酶或牛组织蛋白酶D)的弱得多的抑制剂(IC50 = 6 microM)。已表明它不会被大鼠肝匀浆制剂降解。在体内,它抑制了血浆血浆肾素的活性并降低了呋塞米治疗的食蟹猴的血压。静脉注射5 mg / kg时,明显的降压反应持续3个小时以上。
    DOI:
    10.1021/jm00160a049
  • 作为产物:
    描述:
    N-叔丁氧羰基-N(咪唑)-(4-甲基苯磺酰基)-L-组氨酸碘甲烷 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以72%的产率得到Nα-(tert-butyloxycarbonyl)-Nα-methyl-Nim-tosyl-L-histidine
    参考文献:
    名称:
    设计和合成具有延长的体内作用时间的有效的特异性肾素抑制剂。
    摘要:
    对含有主链Cα-甲基和Nα-甲基修饰的肽进行结构活性分析导致发现了具有高代谢稳定性的有效肾素抑制剂。在体外,Boc-Pro-Phe-Nα-MeHis-Leupsi- [CHOHCH2] Val-Ile-Amp(XII)是人血浆肾素的有效抑制剂,IC50为0.26 nM。它是其他天冬氨酸蛋白酶(如猪胃蛋白酶或牛组织蛋白酶D)的弱得多的抑制剂(IC50 = 6 microM)。已表明它不会被大鼠肝匀浆制剂降解。在体内,它抑制了血浆血浆肾素的活性并降低了呋塞米治疗的食蟹猴的血压。静脉注射5 mg / kg时,明显的降压反应持续3个小时以上。
    DOI:
    10.1021/jm00160a049
点击查看最新优质反应信息

文献信息

  • Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability
    作者:Jacob J. Plattner、Patrick A. Marcotte、Hollis D. Kleinert、Herman H. Stein、Jonathan Greer、Giorgio Bolis、Anthony K. L. Fung、Barbara A. Bopp、Jay R. Luly
    DOI:10.1021/jm00120a006
    日期:1988.12
    A series of renin inhibitors have been prepared and evaluated for their susceptibility to cleavage by the serine protease chymotrypsin. The compounds were designed by consideration of the structural requirements in the active-site region of renin and chymotrypsin. By systematic alteration of the P3 phenylalanine residue, compounds with varying degrees of renin inhibitory potency and chymotrypsin susceptibility were obtained. Selected analogues from this group were examined in vivo for both their hypotensive effects and metabolic patterns.
  • The effects of N-methylation on the enantioselectivity of catalysis by cyclo[(R)-His-(R)-Phe]
    作者:Jason C. Thoen、Mark A. Lipton
    DOI:10.1016/s0957-4166(97)00573-9
    日期:1997.12
    The cyclic dipeptide cyclo[(R)-His-(R)-Phe] 1 has been known since 1981 to catalyze the enantioselective formation of cyanohydrins from aldehydes and HCN. Although 1 has proved to be very effective in the production of optically active cyanohydrins, the precise structure of its catalytically active form remains unresolved. Two derivatives, in which the two amides in 1 were independently N-methylated, were synthesized as probes of the structural and functional requirements for catalysis by 1. Both derivatives were far more soluble in organic solvents and were found to catalyze the formation of racemic cyanohydrin, but differed greatly in their turnover rates. Mixtures of the two derivatives with each other and with 1 were also examined as hydrocyanation catalysts. Only the mixtures containing 1 demonstrated any enantioselectivity, but did not appear any more competent as catalysts than reduced quantities of 1. From these data, it is concluded that both amide bonds are essential for effective catalysis by 1, but that the amide containing the His N-alpha appears to be involved in interactions with the substrate while the other amide plays a structural role, possibly for self-associative hydrogen bonding. (C) 1997 Published by Elsevier Science Ltd. All rights reserved.
  • Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo
    作者:Suvit Thaisrivongs、Donald T. Pals、Douglas W. Harris、Warren M. Kati、Steve R. Turner
    DOI:10.1021/jm00160a049
    日期:1986.10
    A structure-activity analysis of peptides containing backbone C alpha-methyl and N alpha-methyl modifications led to the discovery of potent renin inhibitors with high metabolic stability. In vitro, Boc-Pro-Phe-N alpha-MeHis-Leu psi-[CHOHCH2]Val-Ile-Amp (XII) is a potent inhibitor of human plasma renin with IC50 of 0.26 nM. It is a much weaker inhibitor of other aspartic proteases such as porcine pepsin
    对含有主链Cα-甲基和Nα-甲基修饰的肽进行结构活性分析导致发现了具有高代谢稳定性的有效肾素抑制剂。在体外,Boc-Pro-Phe-Nα-MeHis-Leupsi- [CHOHCH2] Val-Ile-Amp(XII)是人血浆肾素的有效抑制剂,IC50为0.26 nM。它是其他天冬氨酸蛋白酶(如猪胃蛋白酶或牛组织蛋白酶D)的弱得多的抑制剂(IC50 = 6 microM)。已表明它不会被大鼠肝匀浆制剂降解。在体内,它抑制了血浆血浆肾素的活性并降低了呋塞米治疗的食蟹猴的血压。静脉注射5 mg / kg时,明显的降压反应持续3个小时以上。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物